Self Defining Memories in Women Victims of Intimate Partner Violence.

NCT ID: NCT03906487

Last Updated: 2020-07-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-02-06

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A recent report by the World Health Organization demonstrated that 30 % of women worldwide have been victims of intimate-partner violence (IPV). IPV is a public health problem thus it seems important to propose relevant care. It is difficult to carry out an effective therapy. Psychological care is based on cognitive abilities but these women have cognitive impairment. Few studies investigated their cognitive dysfunction. Investigators suggest in this study an exploration of the Self Defining Memories (SDM) which can highlight the loss of identity of these women and a new target of therapy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Intimate partner violence among women is associated to identity problems. Indeed, the victims have a poor self esteem and difficulties to express their own wishes. In this study investigators suggest an analysis of a type of memory, that is known to be essential, to profile an identity functioning: self-defining memories. To date, no study has explored SDM in women with IPV. The characteristics of the SDM in women victims of IPV will be compared to a group of women who has never been diagnosed in this situation. Those memories could be used in therapy. A French adaptation of the questionnaire proposed by Singer \& Moffitt (1992) will be used (Berna et al., 2011a, 2011b) for the assessment of SDM.

Four elements will be study: specificity, meaning, content, affect.

The two groups will have two visits:

* the first to verify inclusion criteria and assessed psychotraumatic and depressive symptoms;
* the last to characterize the SDM.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Domestic Violence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intimate partner violence

The women in this arm must have suffered at least two physical aggressions. They will be recruited in the study as part of their coming to the consultation of intentional injury of the medico-legal unit of the University Hospital Toulouse.

Group Type EXPERIMENTAL

Assessment measures MINI, PCL5 and BDI-II and definition of 5 SDM

Intervention Type BEHAVIORAL

This group will have two visits:

* the first to verify inclusion criteria and assessed psychotraumatic and depressive symptoms by completing assessment measures called MINI, PCL-5, BDI-II ;
* the last to characterize the SDM by defining 5 personal memories

Control group

The women in this group are women who have never experienced domestic violence or have experienced a potentially traumatic event. These women will be recruited by a call for volunteers.

Group Type ACTIVE_COMPARATOR

Assessment measures MINI and definition of 5 SDM

Intervention Type BEHAVIORAL

This group will have two visits:

* the first to verify inclusion criteria and assessed psychotraumatic and depressive symptoms by completing MINI questionary;
* the last to characterize the SDM by and defining 5 personal memories

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Assessment measures MINI, PCL5 and BDI-II and definition of 5 SDM

This group will have two visits:

* the first to verify inclusion criteria and assessed psychotraumatic and depressive symptoms by completing assessment measures called MINI, PCL-5, BDI-II ;
* the last to characterize the SDM by defining 5 personal memories

Intervention Type BEHAVIORAL

Assessment measures MINI and definition of 5 SDM

This group will have two visits:

* the first to verify inclusion criteria and assessed psychotraumatic and depressive symptoms by completing MINI questionary;
* the last to characterize the SDM by and defining 5 personal memories

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

For all participants:

* French mother tongue.
* Informed consent.
* Affiliated to social security

For women who are victims of IPV only:

* Having at least two physical aggressions
* To meet criterion A of the diagnosis of PTSD according to the Diagnostic and Statistical Manual of Mental Disorders DSM (DSM-5) (evaluated using the Mini International Neuropsychiatric Interview, MINI)

For women of the control group only:

\- None a victim of IPV

Exclusion Criteria

For all participants:

* Neurological pathology, brain damage.
* History of head trauma with loss of consciousness.
* Severe, progressive somatic pathology
* Psychotherapy in progress
* Taking psychotropic drugs or beta-blockers (because of their potential impact on memory capacity)
* Pregnant or lactating women
* Under a legal regime for the protection of adults

For women who are victims of IPV only:

* Antecedent or presence of PTSD other than that related to IPV
* History or presence of progressive mental disorders (Axis I DSM-5 - evaluated using Mini International Neuropsychiatric Interview, MINI)

For women of the control group only:

History or presence of progressive mental disorders including PTSD (Axis I DSM-5 - evaluated using Mini International Neuropsychiatric Interview, MINI)
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Toulouse

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Damien PIERRE, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Toulouse

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Toulouse

Toulouse, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Damien PIERRE, MD

Role: CONTACT

(0)5 34 55 75 68 ext. +33

Sophie BILLOUX

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Damien PIERRE, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RC31/19/0051

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.